Pure Global

Lactate Kinetics in Septic Shock - Trial NCT05349370

Access comprehensive clinical trial information for NCT05349370 through Pure Global AI's free database. This phase not specified trial is sponsored by Karolinska University Hospital and is currently Not yet recruiting. The study focuses on Sepsis,Septic Shock. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05349370
Not yet recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT05349370
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Lactate Kinetics in Septic Shock
Lactate Kinetics in Patients Treated for Septic Shock

Study Focus

Sepsis,Septic Shock

Isotopically labeled lactate

Interventional

other

Sponsor & Location

Karolinska University Hospital

Timeline & Enrollment

N/A

May 02, 2022

Dec 31, 2024

60 participants

Primary Outcome

Whole body rate of appearance of lactate

Summary

Lactate kinetics will be studied in hospitalized septic patients using a bolus injection of
 stable isotopically labeled lactate.

ICD-10 Classifications

Septic shock
Other sepsis
Other specified sepsis
Sepsis, unspecified
Sepsis due to other specified staphylococcus

Data Source

ClinicalTrials.gov

NCT05349370

Non-Device Trial